FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer0

• & Crowdsourcing News, CoECI News, Energy & Environment Newsletter, Gaming News Roundup, Gear / Gear News and Events, Global, Global Precipitation, global warming, globalstar, Home, House, News, newsletter, Newsletters, Nexstar Media Wire News, People News, Photovogue / Editorial / News, Politics / Politics News, Property / News, Reviews, reviews-rit-ads, Security / Security News, shop, Shop Beauty, Shopping, starlink, Surface Water, trending-uk, WORLD, World / Middle East
• August 26, 2026

The US Food and Drug Administration has approved a treatment for pancreatic cancer that, in clinical trials, nearly doubled the overall survival time for patients. The drug, daraxonrasib, sold under the brand name Rasonque and manufactured by Revolution Medicines, appears to be a breakthrough in treating one of the world’s deadliest cancers. A late-stage clinical